Related Experiment Videos
Central hypoventilation syndrome in pyruvate dehydrogenase complex deficiency
Pediatrics
|December 1, 1984
Summary
Pyruvate dehydrogenase complex (PDHC) deficiency can cause central hypoventilation syndrome. Peripheral chemoreceptor stimulants like almitrine showed potential for managing this rare condition.
Area of Science:
- Biochemistry
- Neurology
- Pulmonology
Background:
- Pyruvate dehydrogenase complex (PDHC) deficiency is a rare metabolic disorder.
- Central hypoventilation syndrome (CHS) is a life-threatening condition affecting respiratory control.
Observation:
- A boy with PDHC deficiency presented with symptoms of CHS.
- Standard treatments for CHS and metabolic stabilization did not prevent neurological decline.
Findings:
- PDHC activity in patient fibroblasts was significantly reduced.
- Peripheral chemoreceptor stimulants acutely improved ventilation in the patient.
- Dichloroacetate assay accurately identified PDHC deficiency.
Implications:
- PDHC deficiency should be considered in the differential diagnosis of CHS.
- Peripheral chemoreceptor agonists may offer a therapeutic option for CHS in PDHC deficiency.
- Further research is needed to confirm the long-term efficacy of almitrine.